Trials / Completed
CompletedNCT01734707
Atherosclerosis Monitoring and Atherogenicity Reduction Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Institute for Atherosclerosis Research, Russia · Academic / Other
- Sex
- Male
- Age
- 40 Years – 74 Years
- Healthy volunteers
- Accepted
Summary
This study was designed to estimate the effect of two-year treatment with time-released garlic-based drug Allicor on the progression of carotid atherosclerosis in double-blinded placebo-controlled randomized clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Allicor | |
| DRUG | Placebo | Sugar pill manufactured to mimic Allicor 150 mg tablet |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2005-01-01
- Completion
- 2005-10-01
- First posted
- 2012-11-28
- Last updated
- 2012-11-28
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT01734707. Inclusion in this directory is not an endorsement.